positive
1h agoLupin Q2 PAT soars 73% to ₹1,485 crore

Lupin posted a profit after tax of ₹1,484.8 crore for Q2 FY26, up about 72.8% YoY from ₹859.5 crore in Q2 FY25.
The robust earnings helped lift its share price by over 2% on the announcement. Commentators highlight the strength of the company’s generic pipeline and cost optimisations as key drivers.
Lupin’s Q2 PAT jumps ~73% to ₹1,485 cr, highlighting strength in its generics business and cost structure.
M• By Sneha Pathak
Explore:High Return Equity Mutual Fund
positive
1h agoLupin Q2 PAT soars 73% to ₹1,485 crore

Lupin posted a profit after tax of ₹1,484.8 crore for Q2 FY26, up about 72.8% YoY from ₹859.5 crore in Q2 FY25.
The robust earnings helped lift its share price by over 2% on the announcement. Commentators highlight the strength of the company’s generic pipeline and cost optimisations as key drivers.
Lupin’s Q2 PAT jumps ~73% to ₹1,485 cr, highlighting strength in its generics business and cost structure.
M• By Sneha Pathak
Explore:High Return Equity Mutual Fund
Breaking
positive
Lupin Q2 PAT soars 73% to ₹1,485 crore
about 2 hours ago
1 min read
66 words

Lupin Q2 PAT up ~73% to ₹1,485 cr; generics strength and cost Levers driving rebound.
Lupin posted a profit after tax of ₹1,484.8 crore for Q2 FY26, up about 72.8% YoY from ₹859.5 crore in Q2 FY25.
The robust earnings helped lift its share price by over 2% on the announcement. Commentators highlight the strength of the company’s generic pipeline and cost optimisations as key drivers.
Lupin’s Q2 PAT jumps ~73% to ₹1,485 cr, highlighting strength in its generics business and cost structure.

Lupin posted a profit after tax of ₹1,484.8 crore for Q2 FY26, up about 72.8% YoY from ₹859.5 crore in Q2 FY25.
The robust earnings helped lift its share price by over 2% on the announcement. Commentators highlight the strength of the company’s generic pipeline and cost optimisations as key drivers.
Lupin’s Q2 PAT jumps ~73% to ₹1,485 cr, highlighting strength in its generics business and cost structure.
Companies:
Lupin
Tags:
stocks
India
stocks
India
Lupin
pharma
earnings
Nov 8, 2025 • 22:03 IST